Y-Intercept (HK)’s Rockwell Medical RMTI Stock Holding History

Y-Intercept (HK)’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-161	Closed	-$16K	–	867
2021 Q2	$16K	Buy	+161	New	+$16.6K	﹤0.01%	586

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Y-Intercept (HK)'s RMTI Position: Q3 2021 in Review

Y-Intercept (HK) sold out of Rockwell Medical (RMTI) in Q3 2021, closing a stake of 161 shares — an estimated $16K sold.

Y-Intercept (HK) first reported a position in RMTI in Q2 2021 and held it in 1 quarter. The position peaked at $16K in Q2 2021. 62 funds tracked by Wall St. Rank hold RMTI as of Q3 2021.

Y-Intercept (HK) reported no remaining Rockwell Medical position as of Q3 2021 after selling out during the quarter.
Y-Intercept (HK) sold 161 Rockwell Medical shares in Q3 2021, an estimated $16K.
Y-Intercept (HK) first reported a position in Rockwell Medical in Q2 2021 and held it in 1 quarter.
Y-Intercept (HK)'s Rockwell Medical position peaked at $16K in Q2 2021.
62 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2021.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.